Cargando…

Sex Differences in Oral Anticoagulation and Outcomes of Stroke and Intracranial Bleeding in Newly Diagnosed Atrial Fibrillation

BACKGROUND: Female sex is an independent predictor of stroke in patients with atrial fibrillation (AF). Older data suggest undertreatment with anticoagulation among women compared with men. However, it is unknown if novel therapies and updated guidelines have impacted sex differences in AF treatment...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yong, Celina M., Tremmel, Jennifer A., Lansberg, Maarten G., Fan, Jun, Askari, Mariam, Turakhia, Mintu P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7660841/ https://www.ncbi.nlm.nih.gov/pubmed/32394763 http://dx.doi.org/10.1161/JAHA.120.015689

Ejemplares similares

Direct Oral Anticoagulant Adherence of Patients With Atrial Fibrillation Transitioned from Warfarin
por: Pundi, Krishna N., et al.
Publicado: (2021)

Atrial fibrillation bleeding risk and prediction while treated with direct oral anticoagulants in warfarin‐naïve or warfarin‐experienced patients
por: Perino, Alexander C., et al.
Publicado: (2022)

2135 Impact of primary care physician gatekeeping on medication prescriptions for atrial fibrillation
por: Chang, Andrew Y., et al.
Publicado: (2018)

Diagnostic Yield of Extended Cardiac Patch Monitoring in Patients with Stroke or TIA
por: Tung, Christie E., et al.
Publicado: (2015)

Trajectories of Oral Anticoagulation Adherence Among Medicare Beneficiaries Newly Diagnosed With Atrial Fibrillation
por: Hernandez, Inmaculada, et al.
Publicado: (2019)

Outcomes Associated With Oral Anticoagulants Plus Antiplatelets in Patients With Newly Diagnosed Atrial Fibrillation
por: Fox, Keith A. A., et al.
Publicado: (2020)

Early risk of mortality, cardiovascular events, and bleeding in patients with newly diagnosed atrial fibrillation
por: Cavallari, Ilaria, et al.
Publicado: (2020)

Contemporary prevalence estimates of undiagnosed and diagnosed atrial fibrillation in the United States
por: Turakhia, Mintu P., et al.
Publicado: (2023)

Trends in Use of Oral Anticoagulants in Older Adults With Newly Diagnosed Atrial Fibrillation, 2010-2020
por: Ko, Darae, et al.
Publicado: (2022)

Stroke Severity and Outcomes in Patients With Newly Diagnosed Atrial Fibrillation
por: Watanabe, Kotaro, et al.
Publicado: (2021)

Effect of Non-vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patients with Newly Diagnosed Cancer
por: Kim, Kyu, et al.
Publicado: (2018)

Resuming anticoagulation in patients with atrial fibrillation experiencing intracranial hemorrhage
por: Wu, Victor Chien-Chia, et al.
Publicado: (2021)

Challenges of Anticoagulant Therapy in Atrial Fibrillation—Focus on Gastrointestinal Bleeding
por: Scridon, Alina, et al.
Publicado: (2023)

Cost-Effectiveness of Cardiac Radiosurgery for Atrial Fibrillation: Implications for Reducing Health Care Morbidity, Utilization, and Costs
por: Bhatt, Nikhilesh, et al.
Publicado: (2016)

Stroke Incidence and Death in Atrial Fibrillation Patients Newly Treated with Direct Oral Anticoagulants
por: Gabet, Amélie, et al.
Publicado: (2021)

Stent implantation into intracranial part of internal carotid artery in a patient with recurrent stroke, atrial fibrillation and iatrogenic bleeding during anticoagulant therapy
por: Lasek-Bal, Anetta, et al.
Publicado: (2013)

Determinants of label non-adherence to non-vitamin K oral anticoagulants in patients with newly diagnosed atrial fibrillation
por: Seelig, J, et al.
Publicado: (2022)

Anticoagulants in Older Patients with Nonvalvular Atrial Fibrillation after Intracranial Hemorrhage
por: Perreault, Sylvie, et al.
Publicado: (2019)

New Cancer Diagnosis After Bleeding in Anticoagulated Patients With Atrial Fibrillation
por: Raposeiras Roubín, Sergio, et al.
Publicado: (2020)

Adherence and outcomes to direct oral anticoagulants among patients with atrial fibrillation: findings from the veterans health administration
por: Borne, Ryan T., et al.
Publicado: (2017)

Disease understanding in patients newly diagnosed with atrial fibrillation
por: Kaufman, Brystana G, et al.
Publicado: (2018)

Newly Diagnosed Atrial Fibrillation in Acute Myocardial Infarction
por: Obayashi, Yuki, et al.
Publicado: (2021)

Nationwide Study of Sex Differences in Incident Heart Failure in Newly Diagnosed Nonvalvular Atrial Fibrillation
por: Yogasundaram, Haran, et al.
Publicado: (2022)

Impact of Modifiable Bleeding Risk Factors on Major Bleeding in Patients With Atrial Fibrillation Anticoagulated With Rivaroxaban
por: Kirchhof, Paulus, et al.
Publicado: (2020)

Estimated prevalence of undiagnosed atrial fibrillation in the United States
por: Turakhia, Mintu P., et al.
Publicado: (2018)

Efficacy of Ablation Lesion Sets in Addition to Pulmonary Vein Isolation for Paroxysmal Atrial Fibrillation: Findings From the SMASH‐AF Meta‐Analysis Study Cohort
por: Cluckey, Andrew, et al.
Publicado: (2018)

Effect of Adherence to Oral Anticoagulants on Risk of Stroke and Major Bleeding Among Patients With Atrial Fibrillation
por: Yao, Xiaoxi, et al.
Publicado: (2016)

Oral Anticoagulant Use in Patients with Atrial Fibrillation at Low Risk of Stroke and Associated Bleeding Complications
por: Kefale, Adane Teshome, et al.
Publicado: (2023)

Risks associated with discontinuation of oral anticoagulation in newly diagnosed patients with atrial fibrillation: Results from the GARFIELD‐AF Registry
por: Cools, Frank, et al.
Publicado: (2021)

Anticoagulation Holiday: Resumption of Direct Oral Anticoagulants for Atrial Fibrillation in Patients with Index Traumatic Intracranial Hemorrhage
por: Ghenbot, Yohannes, et al.
Publicado: (2022)

Management of oral anticoagulant therapy after intracranial hemorrhage in patients with atrial fibrillation
por: Lucà, Fabiana, et al.
Publicado: (2023)

Oral Anticoagulants for Nonvalvular Atrial Fibrillation in Patients With High Risk of Gastrointestinal Bleeding
por: Lip, Gregory Y. H., et al.
Publicado: (2021)

Bleeding complications in patients with gastrointestinal cancer and atrial fibrillation treated with oral anticoagulants
por: Ording, Anne Gulbech, et al.
Publicado: (2021)

Concomitant Use of Diltiazem With Direct Oral Anticoagulants and Bleeding Risk in Atrial Fibrillation
por: Xu, Yunwen, et al.
Publicado: (2022)

Anticoagulation in atrial fibrillation
por: Steinberg, Benjamin A, et al.
Publicado: (2014)

Stroke and Bleeding Risk in Atrial Fibrillation
por: Senoo, Keitaro, et al.
Publicado: (2014)

Individual and Combined Risk Factors for Incident Atrial Fibrillation and Incident Stroke: An Analysis of 3 Million At-Risk US Patients
por: Chyou, Janice Y, et al.
Publicado: (2015)

An Automated Clinical Alert System for Newly-Diagnosed Atrial Fibrillation
por: Cook, David A., et al.
Publicado: (2015)

Real-world adherence for direct oral anticoagulants in a newly diagnosed atrial fibrillation cohort: does the dosing interval matter?
por: Pham, Phuong N., et al.
Publicado: (2019)

Left atrial appendage closure in atrial fibrillation patients with prior major bleeding or ineligible for oral anticoagulation
por: Wintgens, L. I. S., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_9tb1alnsj8197beh04de6of7db